Common TitleSOLAR-2
Official Title Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Phase Phase II
ClinicalTrials.gov NCT02010255
Treatments
Ledipasvir-Sofosbuvir
Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences